Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AIM/EAH stock hub

AIM/EAH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/EAHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
65.7M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/EAH
In the news

Latest news · AIM/EAH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.6
P25 12.9P50 16.9P75 23.5
Trailing P/E22.3
P25 15.9P50 22.9P75 35.8
ROE5.6
P25 -54.2P50 2.1P75 13.7
ROIC6.7
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/EAH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
236
Groups with data
11
Currency
GBP
Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
200
Employees Change
-24%
Employees Change Percent
-10.71
Enterprise value
GBX 59.8M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
GB0032036807
Last refreshed
2026-05-10
Market cap
GBX 65.7M
Price
GBX 97
Price currency
GBX
Rev Per Employee
429,065x
Sector
Healthcare
Sic
2834
Symbol
aim/EAH
Website
https://ecoanimalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.59%
EV Earnings
19.8x
EV/EBIT
8.81x
EV/EBITDA
6.19x
EV/FCF
6.97x
EV/Sales
0.7x
FCF yield
13.05%
Forward P/E
32.55x
P/B ratio
0.71x
P/E ratio
22.34x
P/S ratio
0.77x
PE Ratio10 Y
63.73x
PE Ratio3 Y
50.16x
PE Ratio5 Y
50.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
7.85%
EBITDA Margin
10.38%
FCF margin
9.99%
Gross margin
49.06%
Gross Profit
GBX 42.1M
Gross Profit Growth
17.23%
Gross Profit Growth Q
46.3%
Gross Profit Growth3 Y
3.77%
Gross Profit Growth5 Y
1.87%
Net Income
GBX 3M
Net Income Growth
358.97%
Net Income Growth Quarters
2%
Net Income Growth Years
3%
Net Income Growth3 Y
42.3%
Net Income Growth5 Y
24.54%
Pretax Margin
7.56%
Profit Margin
3.52%
Profit Per Employee
GBX 15,100
Profitable Years
3
ROA
3.73
Roa5y
3.92
ROCE
6.9
ROE
5.58
Roe5y
5.09
ROIC
6.73
Roic5y
6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
-12.18%
Cagr15y
-4.33%
Cagr1y
49.27%
Cagr20y
-3.4%
Cagr3y
-7.48%
Cagr5y
-23.13%
Div CAGR10
-15.97%
Div CAGR5
0%
EPS Growth
352.1
EPS Growth Quarters
2
EPS Growth Years
3
EPS Growth3 Y
41.88
EPS Growth5 Y
24.18
FCF Growth
70.76%
FCF Growth3 Y
-1.28%
FCF Growth5 Y
-7.02%
OCF Growth
69.92%
OCF Growth10 Y
2.16%
OCF Growth3 Y
-1.86%
OCF Growth5 Y
-10.96%
Revenue Growth
1.44x
Revenue Growth Q
18.74x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
-1.36x
Revenue Growth5 Y
0.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
GBX 0.76
Assets
GBX 114M
Cash
GBX 18.6M
Current Assets
GBX 61.1M
Current Liabilities
GBX 16.4M
Debt
GBX 5.1M
Debt EBITDA
GBX 0.53
Debt Equity
GBX 0.05
Debt FCF
GBX 0.59
Equity
GBX 92.4M
Interest Coverage
22.99
Liabilities
GBX 21.6M
Long Term Assets
GBX 52.9M
Long Term Liabilities
GBX 5.2M
Net Cash
GBX 13.6M
Net Cash By Market Cap
GBX 20.65
Net Cash Growth
-7.31%
Net Debt EBITDA
GBX -1.52
Net Debt Equity
GBX -0.15
Net Debt FCF
GBX -1.58
Tangible Book Value
GBX 41.6M
Tangible Book Value Per Share
GBX 0.61
WACC
4.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.73
Inventory Turnover
2.67
Net Working Capital
GBX 26.8M
Quick ratio
2.75
Working Capital
GBX 44.7M
Working Capital Turnover
GBX 1.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.52%
Dividend per share
GBX 0
Last Dividend
GBX 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-72.71%
1Y total return
49.23%
200-day SMA
93.21
3Y total return
-20.82%
50-day SMA
96.73
50-day SMA vs 200-day SMA
50over200
5Y total return
-73.16%
All Time High
685
All Time High Change
-85.84%
All Time High Date
2017-08-08
All Time Low
33.33
All Time Low Change
191%
All Time Low Date
1992-12-24
ATR
4.58
Beta
0.01
Beta1y
0.21
Beta2y
0.75
Ch YTD
-7.18
High
97
High52
116.9
High52 Date
2026-01-12
High52ch
-17.02%
Low
92
Low52
55.56
Low52 Date
2025-07-11
Low52ch
74.6%
Ma50ch
0.28%
Price vs 200-day SMA
4.07%
RSI
53.97
RSI Monthly
50.65
RSI Weekly
50.88
Sharpe ratio
1.16x
Sortino ratio
2.31
Total Return
-0.52%
Tr YTD
-7.18
Tr15y
-48.53%
Tr1m
10.23%
Tr1w
3.74%
Tr3m
-12.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
GBX 6.7M
Operating Income Growth
101.3
Operating Income Growth3 Y
17.19
Operating Income Growth5 Y
6.37
Operating margin
7.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
59,421,589%
Net Borrowing
-707,000
Shares Insiders
10.17%
Shares Institutions
89.19%
Shares Out
67,759,671
Shares Qo Q
-4.75%
Shares Yo Y
0.52%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
GBX 8.1M
Average Volume
113,477.65x
Bv Per Share
1.25
CAPEX
GBX -325,000
Ch10y
-74.81
Ch15y
-56.89
Ch1m
10.23
Ch1w
3.74
Ch1y
49.23
Ch20y
-65.17
Ch3m
-12.22
Ch3y
-20.82
Ch5y
-73.24
Ch6m
19.75
Change
3.74%
Change From Open
5.43
Close
93.5
Days Gap
-1.6
Depreciation Amortization
2,171,000
Dollar Volume
11,024,923
Earnings Date
2026-07-10
EBIT
GBX 6.7M
EBITDA
GBX 8.9M
EPS
GBX 0.04
F Score
7
FCF
GBX 8.6M
FCF EV Yield
14.35x
FCF Per Share
GBX 0.13
Financing CF
-3,334,000
Fiscal Year End
March
Founded
1,972
Goodwill
17,930,000
Graham Number
110.536
Graham Upside
13.95
Income Tax
GBX 1.4M
Investing CF
-5,117,000
Is Primary Listing
1
Last Earnings Date
2026-03-02
Last Report Date
2025-09-30
Last Split Date
2002-10-18
Last Split Type
Forward
Lynch Fair Value
GBX 107
Lynch Upside
9.84
Ma150
98.05
Ma150ch
-1.07%
Ma20
95.05
Ma20ch
2.05%
Net CF
337,000
Next Earnings Date
2026-07-10
Open
92
P FCF Ratio
7.66
P OCF Ratio
7.38
Position In Range
100
Ppne
8,266,000
Price Date
2026-05-08
Price EBITDA
GBX 7.38
Ptbv Ratio
1.58
Relative Volume
1.05x
Revenue
85,813,000x
SBC By Revenue
0.55x
Share Based Comp
473,000
Tax By Revenue
1.61x
Tax Rate
21.3%
Tr20y
-49.96%
Tr6m
19.75%
Volume
113,659
Z Score
2.9
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/EAH pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/EAH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+49.2%
S&P 500 1Y: n/a
3Y total return
-20.8%
S&P 500 3Y: n/a
5Y total return
-73.2%
S&P 500 5Y: n/a
10Y total return
-72.7%
S&P 500 10Y: n/a
Ownership

Who owns AIM/EAH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+89.2%
Share of float held by funds and institutions
Insider ownership
+10.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.5%
Negative means the company is buying back shares.
Technical

AIM/EAH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
54.0
Neutral momentum band
Price vs 200-day MA
+4.1%
50/200-day relationship not available
Beta (5Y)
0.01
Less volatile than the market
Sharpe ratio
1.16
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/EAH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/EAH stock rating?

aim/EAH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/EAH analysis?

The full report lives at /stocks/aim/EAH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/EAH?

The latest report frames aim/EAH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/EAH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

aim/EAH stock profile: metrics, valuation and analysis | StockMarketAgent.AI